Salix, Dr. Falk Sue Lupin Over Generic Version Of Apriso

Law360, New York (September 7, 2012, 8:00 PM EDT) -- Drugmakers Salix Pharmaceuticals Inc. and Dr. Falk Pharma GmbH on Friday hit rival Lupin Ltd. and its pharmaceutical unit with a patent suit in Delaware federal court seeking to stop Lupin from marketing a generic version of Salix’s ulcerative colitis drug Apriso.

Dr. Falk, which owns the patent, and licensee Salix filed the suit in response to documents Lupin supposedly has filed with the U.S. Food and Drug Administration, including an abbreviated new drug application seeking authorization to market a generic version of mesalamine before the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.